Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective

Figure 2

Kaplan Meier progression to liver-related death or hepatic encephalopathy according to baseline plasma hyaluronic acid (HA) level The figure shows the cumulative risk of liver-related death or development of hepatic encephalopathy for patients divided into three different groups according to the HA level (ng/ml) measured in the first available stored plasma sample from each patient. For patients with HA ≤75 ng/ml (the upper limit of normal) the 5-year risk was only 1%, while patients with HA>250 ng/ml the risk was nearly 45%. Among the included patients 67% were anti-HCV positive, the remaining patients had chronic hepatitis B.

Back to article page